Resumen
The tumor cell content of the receptor for epidermal growth factor (EGF-R) and estrogen receptor (ER) was analyzed in 36 primary breast carcinomas and their metastatic deposits. Twenty-five percent of the primary tumors and 48 percent of the metastases exhibited measurable levels of the receptor. The frequency of EGF-R positivity was the same for cutaneous and lymph node recurrences. No discrepancy was observed with respect to ER content between primary tumors and their metastases.
Idioma original | Inglés |
---|---|
Páginas (desde-hasta) | 849-851 |
Número de páginas | 3 |
Publicación | Anticancer Research |
Volumen | 6 |
N.º | 4 |
Estado | Publicada - jul. 1986 |